Trade BioNTech ^BNTX

Assessing BioNTech (BNTX) Valuation After Goldman Sachs Buy Upgrade And Oncology Growth Focus

BioNTech (NASDAQ:BNTX) Rating Lowered to Market Perform at Leerink Partners

Africa's deep tech boom rests on a fragile research ecosystem

Lingohr Asset Management GmbH Acquires 40,821 Shares of BioNTech SE Sponsored ADR $BNTX

Privium Fund Management B.V. Acquires 8,013 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE Sponsored ADR $BNTX Shares Purchased by Lingohr Asset Management GmbH - Daily Political

BioNTech (NASDAQ:BNTX) vs. uniQure (NASDAQ:QURE) Critical Analysis - Daily Political

Goldman Sachs Highlights BioNTech's (BNTX) Immuno-Oncology and ADC Pipeline

BioNTech Advances Oncology Focus With BNT324 Trial And Leadership Shift

Appointments and advancements for Jan. 29, 2026 | BioWorld

BioNTech SE (BNTX): A Bull Case Theory

BioNTech SE's (NASDAQ:BNTX) Price Is Right But Growth Is Lacking After Shares Rocket 26% - Simply Wall St News

Is BioNTech (BNTX) Pricing Reflect Its mRNA Pipeline Potential After Recent Share Price Gains

BioNTech Shares Surge in 2026 as Analysts See Further Upside

Lbp Am Sa Acquires 47,859 Shares of BioNTech SE Sponsored ADR $BNTX - Zolmax

BioNTech SE Sponsored ADR $BNTX Holdings Boosted by Lbp Am Sa

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Sector Gamma AS Has $2.74 Million Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech (BNTX) Is Up 6.4% After Expanding Late-Stage Oncology Pipeline Ambitions - Has The Bull Case Changed?

Baillie Gifford & Co. Lowers Position in BioNTech SE Sponsored ADR $BNTX

BioNTech (NASDAQ:BNTX) Earns Buy Rating from Berenberg Bank

US Stock Market Today: S&P 500 Futures Rise On Cooling Inflation And Housing Jitters - Simply Wall St News

BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss

BioNTech (NASDAQ:BNTX) Trading 7.5% Higher - Here's Why

The Stock Market Is Closed on MLK Day, but Here's What Goldman Sachs Says to Buy When Trading Resumes | Markets Insider

BioNTech (BNTX) Is Up 7.3% After Unveiling Ambitious Late-Stage Oncology Pipeline Expansion

SG Americas Securities LLC Sells 69,726 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily

A Look At BioNTech (BNTX) Valuation After Expanded Oncology Pipeline Update

BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan

Big Pharma turf war erupts: Bayer sues vaccine makers over alleged stolen mRNA technology - NaturalNews.com

Monsanto Sues COVID-19 Vaccine Manufacturers, Alleging Copyright Infringement | ZeroHedge

Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms

BioNTech (BNTX) Is Up 5.1% After 90%-Effective COVID Data Raises New Franchise Questions

Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach | Malay Mail

Bayer sues Covid-jab makers, alleging patent violation

Bayer's Monsanto Files Lawsuit Against Pfizer, BioNTech, and Moderna Over mRNA Patent Infringement, ETPharma

BioNTech (NasdaqGS:BNTX) Valuation Check After Positive COVID 19 Vaccine Efficacy Data

BioNTech Stock Surges on Regulatory Nod and Analyst Upgrade

AI Podcast: Dollar Weakness and Investment Implications

HSBC: Three 'Painful Trade' Risks Loom if Wall Street Gets It Wrong

Moderna share price jumps as Oppenheimer upgrades stock

Pfizer shares sink on lower COVID revenue prospects

5 Stocks to Fall in Love with this Valentines Day

Stocks make further gains as oil bounce carries on

Zelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks

Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets

US Government Shutdown: Economic Fallout and Political Impasse

Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty

Global Market Overview: Precious Metals Surge Amidst Economic Uncertainty

Japan LDP-Ishin Policy Talks: Paving the Way for a New Prime Minister?

Israel Prepares to Reopen Rafah Crossing Amid Ceasefire Violation Claims

Fed's Rate Cut Conundrum: An Outlook to 2026